Mycobacteria as pathogens of respiratory infection

Infectious Disease Clinics of North America

Volumn 12, Issue 3, 1998, Pages 593-611

  Griffith, D E ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BCG VACCINE; CLARITHROMYCIN; ETHAMBUTOL; INDINAVIR; ISONIAZID; NELFINAVIR; PROTEINASE INHIBITOR; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; RIFAMYCIN; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIUM CULTURE; CLINICAL TRIAL; COLOR DISCRIMINATION; DIARRHEA; DRUG RESPONSE; EPIDEMIC; FLU LIKE SYNDROME; HEARING DISORDER; HEPATITIS; HUMAN; HYPERSENSITIVITY; IMMIGRANT; KIDNEY FAILURE; LEUKOPENIA; META ANALYSIS; MYCOBACTERIUM; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM TUBERCULOSIS; NAUSEA; RECURRENT DISEASE; RESPIRATORY TRACT INFECTION; REVIEW; RHEUMATIC POLYMYALGIA; TASTE DISORDER; THROMBOCYTOPENIA; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES; VISUAL ACUITY; VOMITING;

EID: 0031655759     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70200-2     Document Type: Article

References (70)

1. D.I. Abrams T.F. Mitchell C.C. Child Clofazimine as prophylaxis for disseminated Mycobacterium avium complex infection in AIDS J Infect Dis 167 1993 1459 1463
2. J.M. Aguado F. Pulido S. Moreno Isoniazid prophylaxis for high-risk patients with anergy and HIV infection N Engl J Med 337 1997 1696
3. Ahn C.H. Wallace R.J. Jr L.C. Steele Sulfonamide-containing regimens for disease caused by rifampin-resistant Mycobacterium kansasii Am Rev Respir Dis 135 1987 10 16
4. D. Alland G.E. Kalkut A.R. Moss Transmission of tuberculosis in New York City N Engl J Med 330 1994 1710 1716
5. American Thoracic Society Workshop Rapid diagnostic tests for tuberculosis—What is the appropriate use? Am J Respir Crit Care Med 155 1997 1804 1814
6. P.F. Barnes Rapid diagnostic tests for tuberculosis, progress but no gold standard Am J Respir Crit Care Med 155 1997 1497 1498
7. N.J. Binkin P.L.F. Zuber C.D. Wells Overseas screening for tuberculosis in immigrants and refugees to the United States: Current status Clin Infect Dis 23 1996 1226 1232
8. B.A. Brown D.E. Griffith W. Girard Relationship of adverse events to serum drug levels in patients receiving high-dose azithromycin for mycobacterial lung disease Clin Infect Dis 24 1997 958 964
9. W.J. Burman B.L. Stone R.R. Reves The incidence of false-positive cultures for Mycobacterium tuberculosis Am J Respir Crit Care Med 155 1997 321 326
10. R.E. Campo C.E. Campo Mycobacterium kansasii disease in patients infected with human immunodeficiency virus Clin Infect Dis 24 1997 1233 1238
11. Centers for Disease Control Tuberculosis morbidity—United States 1995 MMWR Morb Mortal Wkly Rep 45 1996 365 370
12. Centers for Disease Control Impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin MMWR Morb Mortal Wkly Rep 45 1996 921 927
13. Centers for Disease Control The role of BCG vaccine in the prevention and control of tuberculosis in the United States MMWR Morb Mortal Wkly Rep 45 1996 1 18
14. Centers for Disease Control Tuberculosis morbidity—United States 1996 MMWR Morb Mortal Wkly Rep 46 1997 695 699
15. Centers for Disease Control Multiple misdiagnoses of tuberculosis resulting from laboratory error—Wisconsin 1996 MMWR Morb Mortal Wkly Rep 46 1997 797 800
16. R.E. Chaisson C.A. Benson M.P. Dube Clarithromycin therapy for bacteremic Mycobacterium avium complex disease Ann Intern Med 121 1994 905 911
17. D.P. Chin P.C. Hopewell D.M. Yajko Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency virus infection J Infect Dis 169 1994 289 295
18. G.J. Dore M.G. Law J.M. Kaldor Isoniazid prophylaxis for high-risk patients with anergy and HIV infection N Engl J Med 337 1997 1697
19. M.P. Dubé F.R. Sattler F.J. Torriani A randomized evaluation of ethambutol for prevention of relapse and drug resistance during treatment of Mycobacterium avium complex bacteremia with clarithromycin-based combination therapy J Infect Dis 176 1997 1225 1232
20. C.R. Friedman M.Y. Stoeckle B.N. Kreiswirth Transmission of multidrug-resistant tuberculosis in a large urban setting Am J Respir Crit Care Med 152 1995 355 359
21. E. Girardi G. Antonucci G. Ippolito Association of tuberculosis risk with the degree of tuberculin reaction in HIV-infected patients Arch Intern Med 157 1997 797 800
22. L.J. Gonzalez-Montaner S. Natal P. Yongchaiyud Rifabutin for the treatment of newly-diagnosed pulmonary tuberculosis: A multinational, randomized, comparative study versus rifampicin Tuber Lung Dis 1993 341 347
23. F.M. Gordin D.L. Cohn P.M. Sullam Early manifestations of disseminated Mycobacterium avium complex disease: A prospective evaluation J Infect Dis 176 1997 126 132
24. F.M. Gordin J.P. Matts C. Miller A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis N Engl J Med 337 1997 315 320
25. D.E. Griffith W.M. Girard Wallace R.J. Jr Clinical features of pulmonary disease caused by rapidly growing mycobacteria: An analysis of 154 patients Am Rev Respir Dis 1993 1271 1278
26. D.E. Griffith B.A. Brown W.M. Girard Adverse events associated with high dose rifabutin in macrolide-containing regimens for Mycobacterium avium complex lung disease Clin Infect Dis 21 1995 594 598
27. D.E. Griffith B.A. Brown W.M. Girard Azithromycin activity against Mycobacterium avium complex lung disease in HIV negative patients Clin Infect Dis 23 1996 983 989
28. D.E. Griffith B.A. Brown Wallace R.J. Jr Varying doses of rifabutin affect white blood cell and platelet counts in human immunodeficiency virus-negative patients who are receiving multidrug regimens for pulmonary Mycobacterium avium complex disease Clin Infect Dis 23 1996 1321 1322
29. D.E. Griffith B.A. Brown D.T. Murphy Initial (six months) results of three times weekly azithromycin in treatment regimens for Mycobacterium avium -complex lung disease in HIV negative patients Chest 1998
30. B. Grinsztejn F.C.O. Fandinho V.G. Veloso Mycobacteria in patients with the acquired immunodeficiency syndrome Arch Intern Med 157 1997 2359 2363
31. E.M. Harrow J.M. Rangel J.M. Arriega Epidemiology and clinical consequences of drug resistant tuberculosis in a Guatemalan hospital Chest 1998
32. D. Havlir M. Dube F. Sattler Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both N Engl J Med 335 1996 392 398
33. Immigration and Naturalization Service Statistical Yearbook of the Immigration and Naturalization Service, 1994 1996 US Government Printing Office Washington, DC 1 228
34. P.A. Jenkins J. Banks I.A. Campbell Mycobacterium kansasii pulmonary infection: A prospective study of the results of nine months of treatment with rifampicin and ethambutol Thorax 49 1994 442 445
35. R.C. Kalayjian Z. Toossi Tomashefski J.F. Jr Pulmonary disease due to infection by Mycobacterium avium complex in patients with AIDS Clin Infect Dis 20 1995 1186 1194
36. C.A. Kemper D. Havlir D. Haghighat The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS J Infect Dis 170 1994 157 164
37. D.R. Leff A.R. Leff Tuberculosis control policies in major metropolitan health department in the United States, VI. Standard of Practice in 1996 Am J Respir Crit Care Med 156 1997 1487 1494
38. N. Markowitz N.I. Hansen P.C. Hopewell Incidence of tuberculosis in the United States among HIV-infected persons Ann Intern Med 126 1997 123 132
39. B.J. Marsh C.F. Reyn J. Edwards The risks and benefits of childhood bacille Calmette-Guérin immunization among adults with AIDS AIDS 11 1997 669 672
40. M.M. McGregor P. Olliaro L. Wolmarans Efficacy and safety of rifabutin in the treatment of patients with newly diagnosed pulmonary tuberculosis Am J Respir Crit Care Med 154 1996 1462 1467
41. M.T. McKenna E. McCray I. Onorato The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993 N Engl J Med 332 1995 1071 1076
42. M. Moore I.M. Onorato E. McCray Trends in drug-resistant tuberculosis in the United States, 1993–1996 JAMA 278 1997 833 837
43. R.D. Moore R.E. Chaisson Survival analysis of two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex in AIDS AIDS 9 1995 1337 1342
44. K. Nakata W.N. Rom Y. Honda Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung Am J Respir Crit Care Med 155 1997 996 1003
45. Nelson KG, Griffith DE, Brown BA, et al: Results in surgery in Mycobacterium avium-intracellulare lung disease. The Annals of Thoracic Surgery, in press
46. S.D. Nightingale D.W. Cameron F.M. Gordin Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS N Engl J Med 329 1993 828 833
47. Perriëns J.H. St Louis ME, Mukadi YB, et al: Pulmonary tuberculosis in HIV-infected patients in Zaire—A controlled trial of treatment for either 6 or 12 months N Engl J Med 332 1995 779 784
48. M. Pierce S. Crampton D. Henry A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome N Engl J Med 335 1996 384 391
49. S.C. Piscitelli C. Flexner J.R. Minor Drug interactions in patients infected with human immunodeficiency virus Clin Infect Dis 23 1996 685 693
50. D.S. Prince D.D. Peterson R.M. Steinger Infection with Mycobacterium avium complex in patients without predisposing conditions N Engl J Med 321 1989 863 868
51. F. Pulido J.M. Peña R. Rubio Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients Arch Intern Med 157 1997 227 232
52. Raviglione M.C. Snider D.E. Jr A. Kochi Global epidemiology of tuberculosis: Morbidity and mortality of a worldwide epidemic JAMA 273 1995 220 226
53. J. Sauret S. Hernandez-Flix E. Castro Treatment of pulmonary disease caused by Mycobacterium kansasii: Results of 18 vs 12 months' chemotherapy Tuber Lung Dis 76 1995 104 108
54. S. Schwander S. Rüsch-Gerdes A. Mateega A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis Tuber Lung Dis 76 1995 210 218
55. S. Shafran J. Singer D.P. Zarowny A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: Rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin N Engl J Med 335 1996 377 383
56. P. Small N. McClerry S. Singh Molecular strain typing of Mycobacterium tuberculosis to confirm cross resistance in the AFB laboratory and modification of procedures to manage occurrences of false positive cultures J Clin Microbiol 31 1993 1677 1682
57. P.M. Small P.C. Hopewell S.P. Singh The epidemiology of tuberculosis in San Francisco—A population-based study using conventional and molecular methods N Engl J Med 330 1994 1703 1709
58. Wallace R.J. Jr R. O'Brien J. Glassroth Diagnosis and treatment of disease caused by nontuberculous mycobacteria Am Rev Respir Dis 142 1990 940 953
59. Wallace R.J. Jr B.A. Brown D.E. Griffith Drug intolerance to high-dose clarithromycin among elderly patients Diagn Microbiol Infect Dis 16 1993 215 221
60. Wallace R.J. Jr D. Dunbar B.A. Brown Rifampin-resistant Mycobacterium kansasii Clin Infect Dis 18 1994 736 743
61. Wallace R.J. Jr B.A. Brown D.E. Griffith Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease Am J Respir Crit Care Med 149 1994 1835 1841
62. Wallace R.J. Jr B.A. Brown D.E. Griffith Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium-M. intracellulare infection J Infect Dis 171 1995 747 750
63. Wallace R.J. Jr B.A. Brown D.E. Griffith Clarithromycin regimens for pulmonary Mycobacterium avium complex: The first 50 patients Am J Respir Crit Care Med 153 1996 1766 1772
64. Wallace R.J. Jr J. Glassroth D.E. Griffith American Thoracic Society: Diagnosis and treatment of disease caused by nontuberculous mycobacteria Am J Respir Crit Care Med 156 1997 S1 S25
65. Wallace RJ Jr, Zhang Y, Brown BA, et al: Individual patients with nodular bronchiectasis lung disease are infected with multiple genotypes and serovars of Mycobacterium avium complex. Submitted to Am J Respir and Critical Care Med
66. C.D. Wells P.L.F. Zuber C.M. Nolan Tuberculosis prevention among foreign-born persons in Seattle–King County, Washington Am J Respir Crit Care Med 156 1997 573 577
67. C. Whalen C.R. Horsburgh D. Hom Accelerated course of human immunodeficiency virus infection after tuberculosis Am J Respir Crit Care Med 151 1995 129 135
68. R.S. Witzig B.A. Fazal R.M. Mera Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1 Clin Infect Dis 21 1995 77 85
69. P.L.F. Zuber M.T. McKenna N.J. Binkin Long-term risk of tuberculosis among foreign-born persons in the United States JAMA 278 1997 304 307
70. 1997 USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus Ann Intern Med 127 1997 923 946